87939-27-3

Basic information

• Product Name: 1,5-diphenyl-2-{3-[4-(pyridin-2-yl)piperazin-1-yl]propyl}-1,2-dihydro-3H-pyrazol-3-one hydrochloride (1:1)
• Synonyms: 3H-Pyrazol-3-one, 1,2-dihydro-1,5-diphenyl-2-(3-(4-(2-pyridinyl)-1-piperazinyl)propyl)-, monohydrochloride
• CAS NO: 87939-27-3
• Molecular Formula: C₂₇H₃₀ClN₅O
• Molecular Weight: 476.013
• Mol File: 87939-27-3.mol

Chemical Properties

• Boiling Point: 625°C at 760 mmHg
• Flash Point: 331.8°C
• Vapor Pressure: 1.54E-15mmHg at 25°C
• CAS DataBase Reference: 1,5-diphenyl-2-{3-[4-(pyridin-2-yl)piperazin-1-yl]propyl}-1,2-dihydro-3H-pyrazol-3-one hydrochloride (1:1)(CAS DataBase Reference)
• NIST Chemistry Reference: 1,5-diphenyl-2-{3-[4-(pyridin-2-yl)piperazin-1-yl]propyl}-1,2-dihydro-3H-pyrazol-3-one hydrochloride (1:1)(87939-27-3)
• EPA Substance Registry System: 1,5-diphenyl-2-{3-[4-(pyridin-2-yl)piperazin-1-yl]propyl}-1,2-dihydro-3H-pyrazol-3-one hydrochloride (1:1)(87939-27-3)

Safety Data

• Hazardous Substances Data: 87939-27-3(Hazardous Substances Data)

Usage

Chemical structure

The compound has a complex molecular structure that includes a pyrazolone core, a piperazine ring, and a pyridine group.

Salt form

It is found in the form of a hydrochloride salt.

Potential pharmaceutical agent

It has various biological activities and potential therapeutic applications.

Further research needed

More research is necessary to fully understand its properties and potential uses.

Molecular weight

The molecular weight of the compound is approximately 421.98 g/mol.

Appearance

The compound is likely to be a solid, although the specific appearance (e.g., color, crystal structure) is not provided in the material.

Solubility

The solubility of the compound in various solvents is not provided in the material, but it is likely to be soluble in water due to the presence of the hydrochloride salt.

Stability

The stability of the compound under different conditions (e.g., temperature, pH, light exposure) is not provided in the material.

Safety and toxicity

Information on the safety and toxicity of the compound is not provided in the material, but it is important to consider these factors when evaluating its potential as a pharmaceutical agent.

Synthesis

The synthesis method for the compound is not provided in the material, but it is likely to involve the formation of the pyrazolone core, the piperazine ring, and the attachment of the pyridine group.

Biological activity

The specific biological activities of the compound are not provided in the material, but it is mentioned that it has potential therapeutic applications.

Therapeutic applications

The potential therapeutic applications of the compound are not provided in the material, but further research is necessary to fully understand its properties and potential uses.